Vasisht Tadigotla

Title: Vasisht Tadigotla: Innovator in Medical Diagnostics

Introduction

Vasisht Tadigotla is a prominent inventor based in Newton, MA, known for his significant contributions to the field of medical diagnostics. With a total of four patents to his name, he has focused on developing innovative methods for detecting critical health conditions.

Latest Patents

One of his latest patents is titled "Methods of detecting renal transplant rejection using microvesicle nucleic acid biomarkers." This invention utilizes microvesicle biomarkers, including nucleic acids and proteins, to assess and monitor kidney transplant rejection in patients. Another notable patent is "Methods and compositions to detect mutations in plasma using exosomal RNA and cell-free DNA from non-small cell lung cancer patients." This invention provides methods and kits for detecting biomarkers, such as Epidermal Growth Factor Receptor (EGFR) mutations, to aid in the diagnosis and treatment of lung cancer.

Career Highlights

Throughout his career, Vasisht has worked with esteemed organizations, including Exosome Diagnostics, Inc. and Brigham and Women's Hospital. His work has significantly advanced the understanding and detection of various medical conditions, particularly in the realm of cancer and transplant medicine.

Collaborations

Vasisht has collaborated with notable professionals in his field, including Robert Kitchen and James Hurley. These partnerships have contributed to the development of his innovative patents and have enhanced the impact of his work in medical diagnostics.

Conclusion

Vasisht Tadigotla's contributions to medical diagnostics through his innovative patents demonstrate his commitment to improving patient care. His work continues to influence the field and offers promising advancements in the detection and monitoring of critical health conditions.